Journal
Biomedicines
Publication Date
4-7-2022
Volume
10
Issue
4
First Page
870
Document Type
Open Access Publication
DOI
10.3390/biomedicines10040870
Rights and Permissions
Gondré-Lewis, M.C.; Elman, I.; Alim, T.; Chapman, E.; Settles-Reaves, B.; Galvao, C.; Gold, M.S.; Baron, D.; Kazmi, S.; Gardner, E.; Gupta, A.; Dennen, C.; Blum, K. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? Biomedicines 2022, 10, 870. doi.org/10.3390/biomedicines10040870 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Recommended Citation
Gondré-Lewis, Marjorie C; Elman, Igor; Alim, Tanya; Chapman, Edwin; Settles-Reaves, Beverlyn; Galvao, Carine; Gold, Mark S; Baron, David; Kazmi, Shan; Gardner, Eliot; Gupta, Ashim; Dennen, Catherine; and Blum, Kenneth, "Frequency of the dopamine receptor D3 (rs6280) vs. opioid receptor µ1 (rs1799971) polymorphic risk alleles in patients with opioid use disorder: A preponderance of dopaminergic mechanisms?." Biomedicines. 10, 4. 870 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11719
